This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
When discussing heart health, heart attacks and cardiacarrest are two terms that are often mistaken for one another. Understanding the difference between heart attack and cardiacarrest can help in recognizing symptoms, seeking prompt medical care, and even saving lives. What is CardiacArrest?
“Particularly, his contributions to the sudden cardiacarrest medical knowledge base have changed the way we think about this deadly condition that we might be able to prevent on a larger scale.” Although “sudden cardiacarrest” and “heart attack” are often mistaken to be the same, the conditions are quite different.
Beta-blockers , which slow the heart rate and reduce blood pressure. Anticoagulants to prevent bloodclots. BloodClots: An enlarged heart is more prone to developing bloodclots, which can lead to stroke or pulmonary embolism. Antiarrhythmics to help manage abnormal heart rhythms.
The label includes a “black box” warning for CV risk due to bloodclots. February 2024 FDA Approvals: Innovations in Cardiovascular Interventions XACT Carotid Stent System (Approved: 02/07/2024) This approval expands the indications to be used during a Transcarotid Artery Revascularization (TCAR) procedure to prevent future strokes.
It occurs when blood flow to the coronary arteries is restricted, frequently by a bloodclot, which can harm the heart muscle and result in consequences like heart disease or sudden cardiacarrest. A human's health and well-being may suffer significantly after a heart attack.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content